Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin for VTE Prophylaxis in Glioblastoma
NCT00790452Phase 2Terminated
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Nov 2008
- Primary completion
- Oct 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of aspirin in venous thromboembolism (VTE), sponsored by University of Texas MD Anderson Cancer Center. Started Nov 2008; status: terminated.
02
Drugs
aspirin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT00790452.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00790452.